ArticleMolecular diversity2025
Repurposing FDA-approved drugs for combating tigecycline resistance in Acinetobacter baumannii: in silico screening against BaeR protein.
Karthika Alagesan et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it